Nutrition Journal Publishes Double-Blind, Placebo-Controlled Clinical Study of Ambrotose AO® Capsules
A randomized, double‐blind, placebo‐controlled crossover trial investigating the antioxidant effects of Ambrotose AO capsules in healthy, exercise-trained and untrained men and women was published on November 1, 2010, in the Nutrition Journal.† In this study, scientists from the University of Memphis showed that Ambrotose AO (4 capsules/day for 3 weeks) significantly increased two measures of antioxidant capacity—Oxygen Radical Absorbance Capacity (ORAC) and Trolox Equivalent Antioxidant Capacity (TEAC)—in the blood of healthy men and women at rest.* Compared to placebo, Ambrotose AO capsules also caused a greater increase in blood ORAC at 30 minutes post exercise.* This study also supports the safety of Mannatech’s Ambrotose AO supplement at a daily dose of 4 capsules, through measurement of complete blood count, metabolic and lipid panel, and supports prior evidence for Ambrotose AO capsules to enhance blood antioxidant capacity in healthy individuals at rest and following exercise.* The trial was led by Dr. Richard J. Bloomer, Associate Professor and Director of the Cardiorespiratory/Metabolic Laboratory in the Department of Health and Sport Sciences at the University of Memphis, Memphis Tennessee, and students Robert E. Canale, Megan M. Blankenship and Kelsey H. Fisher‐Wellman.
- Bloomer RJ, Canale RE, Blankenship MM, Fisher-Wellman KH. (2010) Effect of Ambrotose AO® on resting and exercise-induced antioxidant capacity and oxidative stress in healthy adults. Nutrition Journal, 9:49. doi:10.1186/1475-2891-9-49.